21
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Bibliometric Analysis of Cough Variant Asthma from 1993 to 2022

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon &
Pages 517-537 | Received 29 Nov 2023, Accepted 15 May 2024, Published online: 03 Jun 2024

References

  • Côté A, Russell RJ, Boulet LP, et al. Managing chronic cough due to asthma and NAEB in adults and adolescents: CHEST guideline and expert panel report. Chest. 2020;158(1):68–96. doi:10.1016/j.chest.2019.12.021
  • Zhou J, Yi F, Wu F, et al. Characteristics of different asthma phenotypes associated with cough: a prospective, multicenter survey in China. Respir Res. 2022;23(1):243. doi:10.1186/s12931-022-02104-8
  • Song WJ, Kim HJ, Shim JS, et al. Diagnostic accuracy of fractional exhaled nitric oxide measurement in predicting cough-variant asthma and eosinophilic bronchitis in adults with chronic cough: a systematic review and meta-analysis. J Allergy Clin Immunol. 2017;140(3):701–709. doi:10.1016/j.jaci.2016.11.037
  • Hao H, Pan Y, Xu Z, et al. Prediction of bronchodilation test in adults with chronic cough suspected of cough variant asthma. Front Med. 2022;9:987887. doi:10.3389/fmed.2022.987887
  • Kim CK, Kim JT, Kang H, Yoo Y, Koh YY. Sputum eosinophilia in cough-variant asthma as a predictor of the subsequent development of classic asthma. Clin Exp Immunol. 2003;33(10):1409–1414. doi:10.1046/j.1365-2222.2003.01788.x
  • Todokoro M, Mochizuki H, Tokuyama K, Morikawa A. Childhood cough variant asthma and its relationship to classic asthma. Ann Allergy Asthma Immunol. 2003;90(6):652–659. doi:10.1016/S1081-1206(10)61871-6
  • Terasaki G, Paauw DS. Evaluation and treatment of chronic cough. Med Clin North Am. 2014;98(3):391–403. doi:10.1016/j.mcna.2014.01.002
  • Qi R, Xue Z, Liu Y. Visualization and analysis of the mapping knowledge domain of acupuncture and central nervous system cell apoptosis. Evid Based Complement Alternat Med. 2022;2022:1751702. doi:10.1155/2022/1751702
  • Zhen G, Yingying L, Weifang X, Jingcheng D. A bibliometric and scientific knowledge map study of the drug therapies for asthma-related study from 1982 to 2021. Front Pharmacol. 2022;13:916871. doi:10.3389/fphar.2022.916871
  • Wang J, Maniruzzaman M. A global bibliometric and visualized analysis of bacteria-mediated cancer therapy. Drug Discov Today. 2022;27(10):103297. doi:10.1016/j.drudis.2022.05.023
  • Wu F, Gao J, Kang J, et al. Knowledge mapping of exosomes in autoimmune diseases: a bibliometric analysis (2002–2021). Front Immunol. 2022;13:939433. doi:10.3389/fimmu.2022.939433
  • AlRyalat SAS, Malkawi LW, Momani SM. Comparing bibliometric analysis using PubMed, Scopus, and Web of Science databases. J Vis Exp. 2019;152. doi:10.3791/58494
  • Falagas ME, Pitsouni EI, Malietzis GA, Pappas G. Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses. FASEB J. 2008;22(2):338–342. doi:10.1096/fj.07-9492LSF
  • Hua N, Tan X, He Y, Sun M, Wang X. Medical decision-making for adolescents with depression: a bibliometric study and visualization analysis via CiteSpace. Int J Ment Health Nurs. 2023;32(2):365–377. doi:10.1111/inm.13085
  • Wei N, Xu Y, Li Y, et al. A bibliometric analysis of T cell and atherosclerosis. Front Immunol. 2022;13:948314. doi:10.3389/fimmu.2022.948314
  • Zhang J, Song L, Jia J, et al. Knowledge Mapping of Necroptosis From 2012 to 2021: a Bibliometric Analysis. Front Immunol. 2022;13:917155. doi:10.3389/fimmu.2022.917155
  • Matsumoto H, Niimi A, Tabuena RP, et al. Airway wall thickening in patients with cough variant asthma and nonasthmatic chronic cough. Chest. 2007;131(4):1042–1049. doi:10.1378/chest.06-1025
  • Lai K, Satia I, Song WJ, et al. Cough and cough hypersensitivity as treatable traits of asthma. Lancet Respir Med. 2023;11(7):650–662. doi:10.1016/S2213-2600(23)00187-X
  • Chang AB, Oppenheimer JJ, Irwin RS. CHEST expert cough panel. managing chronic cough as a symptom in children and management algorithms: CHEST guideline and expert panel report. Chest. 2020;158(1):303–329. doi:10.1016/j.chest.2020.01.042
  • Irwin RS, Baumann MH, Bolser DC, et al. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 Suppl):1S–23S. doi:10.1378/chest.129.1_suppl.1S
  • Fujimura M, Abo M, Ogawa H, et al. Importance of atopic cough, cough variant asthma and sinobronchial syndrome as causes of chronic cough in the Hokuriku area of Japan. Respirology. 2005;10(2):201–207. doi:10.1111/j.1440-1843.2005.00686.x
  • Friedrich C, Francke K, Birring SS, et al. The P2X3 receptor antagonist filapixant in patients with refractory chronic cough: a randomized controlled trial. Respir Res. 2023;24(1):109. doi:10.1186/s12931-023-02384-8
  • Li Y, Zheng JJ, Wu X, Gao W, Liu CJ. Postural control of Parkinson’s disease: a visualized analysis based on Citespace knowledge graph. Front Aging Neurosci. 2023;15:1136177. doi:10.3389/fnagi.2023.1136177
  • Jiang S, Liu Y, Zheng H, et al. Evolutionary patterns and research frontiers in neoadjuvant immunotherapy: a bibliometric analysis. Int J Surg. 2023;109(9):2774–2783. doi:10.1097/JS9.0000000000000492
  • Li Y, Zhou Y, Wang L, et al. Emerging trends and hotspots in the links between the gut microbiota and MAFLD from 2002 to 2021: a bibliometric analysis. Front Endocrinol. 2022;13:990953. doi:10.3389/fendo.2022.990953
  • Corrao WM, Braman SS, Irwin RS. Chronic cough as the sole presenting manifestation of bronchial asthma. N Engl J Med. 1979;300(12):633–637. doi:10.1056/NEJM197903223001201
  • Irwin RS, Curley FJ, French CL. Chronic cough. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Am Rev Respir Dis. 1990;141(3):640–647. doi:10.1164/ajrccm/141.3.640
  • Fujimura M, Ogawa H, Nishizawa Y, Nishi K. Comparison of atopic cough with cough variant asthma: is atopic cough a precursor of asthma? Thorax. 2003;58(1):14–18. doi:10.1136/thorax.58.1.14
  • Niimi A, Amitani R, Suzuki K, et al. Eosinophilic inflammation in cough variant asthma. Eur Respir J.1998;11(5):1064–1069. doi:10.1183/09031936.98.11051064.
  • Niimi A, Matsumoto H, Minakuchi M, et al. Airway remodelling in cough-variant asthma. Lancet. 2000;356(9229):564–565. doi:10.1016/s0140-6736(00)02584–8.
  • Gibson PG, Dolovich J, Denburg J, et al. Chronic cough: eosinophilic bronchitis without asthma. Lancet. 1989;1(8651):1346–1348. doi:10.1016/s0140-6736(89)92801–8.
  • Brightling CE, Ward R, Goh KL, et al. Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med. 1999;160(2):406–410. doi:10.1164/ajrccm.160.2.9810100.
  • Irwin RS, French CT, Smyrnios NA, Curley FJ. Interpretation of positive results of a methacholine inhalation challenge and 1 week of inhaled bronchodilator use in diagnosing and treating cough-variant asthma. Arch Intern Med. 1997;157(17):1981–1987. doi:10.1001/archinte.1997.00440380091009.
  • Committee for the Japanese Respiratory Society Guidelines for Management of Cough, Kohno S, Ishida T, et al. The Japanese Respiratory Society guidelines for management of cough. Respirology. 2006;11 Suppl 4:S135–186.
  • Cheng K, Zhou Y, Wu H. Bibliometric analysis of global research trends on monkeypox: are we ready to face this challenge? J Med Virol. 2023;95(1):e27892. doi:10.1002/jmv.27892
  • Glauser FL. Variant asthma. Ann Allergy. 1972;30(8):457–459.
  • Morice AH, Millqvist E, Bieksiene K, et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Resp J. 2020;55(1):1901136. doi:10.1183/13993003.01136-2019
  • Gibson PG, Fujimura M, Niimi A. Eosinophilic bronchitis: clinical manifestations and implications for treatment. Thorax. 2002;57(2):178–182. doi:10.1136/thorax.57.2.178
  • Moon HG, Kim SJ, Lee MK, et al. Colony-stimulating factor 1 and its receptor are new potential therapeutic targets for allergic asthma. Allergy. 2020;75(2):357–369. doi:10.1111/all.14011
  • Koh YY, Jeong JH, Park Y, Kim CK. Development of wheezing in patients with cough variant asthma during an increase in airway responsiveness. Eur Respir J. 1999;14(2):302–308. doi:10.1034/j.1399-3003.1999.14b11.x
  • Liu M, Liu K, Zhu N, Xia J, Chen X. Inflammatory mediators in induced sputum and airway hyperresponsiveness in cough variant asthma during long-term inhaled corticosteroid treatment. Mediators Inflamm. 2012;2012:403868. doi:10.1155/2012/403868
  • De Diego A, Martínez E, Perpiñá M, et al. Airway inflammation and cough sensitivity in cough-variant asthma. Allergy. 2005;60(11):1407–1411. doi:10.1111/j.1398-9995.2005.00609.x
  • Zhan W, Wu F, Zhang Y, et al. Identification of cough-variant asthma phenotypes based on clinical and pathophysiologic data. J Allergy Clin Immunol. 2023;152(3):622–632. doi:10.1016/j.jaci.2023.04.017
  • Jayaram L, Parameswaran K, Sears MR, Hargreave FE. Induced sputum cell counts: their usefulness in clinical practice. Eur Respir J. 2000;16(1):150–158. doi:10.1034/j.1399-3003.2000.16a27.x
  • Birring SS, Parker D, Brightling CE, Bradding P, Wardlaw AJ, Pavord ID. Induced sputum inflammatory mediator concentrations in chronic cough. Am J Respir Crit Care Med. 2004;169(1):15–19. doi:10.1164/rccm.200308-1092OC
  • Malerba M, Ragnoli B, Azzolina D, Montuschi P, Radaeli A. Predictive markers of bronchial hyperreactivity in a large cohort of young adults with cough variant asthma. Front Pharmacol. 2021;12:630334. doi:10.3389/fphar.2021.630334
  • Wang Y, Zhao L, Chen F, et al. Diagnostic value of fractional exhaled nitric oxide and small airway function in differentiating cough-variant asthma from typical asthma. Can Respir J. 2021;2021:9954411. doi:10.1155/2021/9954411
  • Bai H, Shi C, Yu S, et al. A comparative study on the value of lower airway exhaled nitric oxide combined with small airway parameters for diagnosing cough-variant asthma. Ther Adv Respir Dis. 2023;17:17534666231181259. doi:10.1177/17534666231181259
  • Liu X, Wang X, Yao X, Wang Y, Sun Y, Zhang L. Value of exhaled nitric oxide and FEF25-75 in Identifying factors associated with chronic cough in allergic rhinitis. Allergy Asthma Immunol Res. 2019;11(6):830–845. doi:10.4168/aair.2019.11.6.830
  • Dicpinigaitis PV, Dobkin JB, Reichel J. Antitussive effect of the leukotriene receptor antagonist zafirlukast in subjects with cough-variant asthma. J Asthma. 2002;39(4):291–297. doi:10.1081/jas-120002285
  • Yi F, Zhan C, Liu B, et al. Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma. Respir Res. 2022;23(1):279. doi:10.1186/s12931-022-02114-6
  • Si Z, Zhang B. Amygdalin attenuates airway epithelium apoptosis, inflammation, and epithelial-mesenchymal transition through restraining the TLR4/NF-κB signaling pathway on LPS-treated BEAS-2B bronchial epithelial cells. Int Arch Allergy Immunol. 2021;182(10):997–1007. doi:10.1159/000514209
  • Li P, Wang J, Wang C, et al. Therapeutic effects and mechanisms study of hanchuan zupa granule in a guinea pig model of cough variant asthma. J Ethnopharmacol. 2021;269:113719. doi:10.1016/j.jep.2020.113719
  • Koh YY, Chae SA, Min KU. Cough variant asthma is associated with a higher wheezing threshold than classic asthma. Clin Exp Allergy. 1993;23(8):696–701. doi:10.1111/j.1365-2222.1993.tb01796.x
  • Chen J, Lin W, Gu H, Ying K, Li T, Shao H. Study on the relationship between bronchoalveolar lavage fluid cell count, Th1/Th2 cytokines and pulmonary function in patients with cough variant asthma. J Asthma Allergy. 2022;15:1713–1720. doi:10.2147/JAA.S383128
  • Fujimura M, Ohkura N, Abo M, et al. Exhaled nitric oxide levels in patients with atopic cough and cough variant asthma. Respirology. 2008;13(3):359–364. doi:10.1111/j.1440-1843.2008.01273.x
  • Tajiri T, Niimi A, Matsumoto H, et al. Prevalence and clinical relevance of allergic rhinitis in patients with classic asthma and cough variant asthma. Respiration. 2014;87(3):211–218. doi:10.1159/000355706